About Kemwell
Kemwell is a Healthcare company based in Bengaluru (India) founded in 1980. It provides comprehensive CDMO services for the pharmaceutical industry. It operates on a B2B model. The company has 296 employees. Its Indian entity Kemwell Biopharma Private Limited reported revenue of ₹239 Cr. Its focus areas include Pharmaceutical Services, Contract Development and Manufacturing and Diversified Services. Its competitors include Syngene, Piramal Group and Panacea Biotec; 1 of its 3 listed competitors has raised funding.
Company details
Kemwell, established in 1980, excels in providing healthcare solutions, pharmaceutical services, contract development and manufacturing, and diversified services. Provides comprehensive CDMO services for the pharmaceutical industry. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Bengaluru, India
- Employees 296
- SectorsHealthcare
- Website kemwellpharma.com
- Legal Name Kemwell Biopharma Private Limited
- Date of Incorporation 07 May, 2008
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹239 Cr
FY 2025 · +10% YoY
- Net Loss-₹19.09 Cr
FY 2025 · -8% margin
- EBITDA₹1.73 Cr
FY 2025 · 1% margin
- Employee Count296
Associated legal entities of Kemwell
Kemwell operates through Kemwell Biopharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kemwell Biopharma Private Limited CIN U24232KA2008PTC046341 | Active | 07 May 2008 | Bangalore, Karnataka | ₹239 Cr | 296 | 2 | View details |
Board of directors of Kemwell Biopharma Private Limited (Kemwell)
Kemwell Biopharma Private Limited is the primary company behind Kemwell. The board of Kemwell Biopharma Private Limited currently have 2 directors; the longest-serving is Anurag Bagaria, appointed in 2008. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anurag Bagaria DIN 00111917 | Director | 07 May 2008 | 18 yrs 5 mo | Kemwell Biopharma Private Limited |
| Neha Anurag Bagaria DIN 00178703 | Director | 21 Jun 2024 | 2 yrs 4 mo | Kemwell Biopharma Private Limited |
Financials of Kemwell
Figures of Kemwell Biopharma Private Limited, the primary company behind Kemwell, for FY 2025. Revenue was ₹239 Cr (+10% year on year). Net loss was -₹19.09 Cr (-8% margin). EBITDA was ₹1.73 Cr (1% margin). Revenue has grown at a compounded annual rate of +30% over three years and +52% over five years.
- ₹239 CrRevenue · FY 2025 · +10% YoY
- -₹19.09 CrNet loss · -8% margin
- ₹1.73 CrEBITDA · 1% margin
- ₹5.13 CrPaid-up capital
- 296Employees (provident fund records)
- +30%Revenue CAGR, 3 years
- +52%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Kemwell Biopharma Private Limited are on its company page.
Detailed financial statements for Kemwell
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Kemwell
Kemwell has 3 listed competitors in our database, 1 of them funded. They include Syngene, Piramal Group and Panacea Biotec.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| syngeneintl.com | 1993 | Bengaluru, India | $85.89M | 5,618 | Provider of contract research and manufacturing services for both small molecules and biologics | |
| piramal.com | 1984 | Mumbai, India | 204 | Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | ||
| panaceabiotec.com | 1984 | Ambala, India | 2,095 | Developer of biosimilars, vaccines and natural products |
Detailed competitors of Kemwell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kemwell
Complete news archive for Kemwell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kemwell
Kemwell was founded in 1980.
Kemwell is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Kemwell has 296 employees.
The primary company behind Kemwell, Kemwell Biopharma Private Limited, reported revenue of ₹239 Cr for FY 2025, up 10% year on year.
Kemwell, established in 1980, excels in providing healthcare solutions, pharmaceutical services, contract development and manufacturing, and diversified services. Provides comprehensive CDMO services for the pharmaceutical industry. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Kemwell's top competitors include Syngene, Panacea Biotec and Piramal Group.
Kemwell operates through Kemwell Biopharma Private Limited.
The legal entities of Kemwell currently have 2 directors, including Anurag Bagaria, Neha Anurag Bagaria.